NZ775291A - Aerosolisable formulation - Google Patents

Aerosolisable formulation

Info

Publication number
NZ775291A
NZ775291A NZ775291A NZ77529119A NZ775291A NZ 775291 A NZ775291 A NZ 775291A NZ 775291 A NZ775291 A NZ 775291A NZ 77529119 A NZ77529119 A NZ 77529119A NZ 775291 A NZ775291 A NZ 775291A
Authority
NZ
New Zealand
Prior art keywords
aerosolised formulation
aerosolised
acid
present
formulation
Prior art date
Application number
NZ775291A
Other versions
NZ775291B2 (en
Inventor
Ross Cabot
Original Assignee
Nicoventures Trading Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nicoventures Trading Ltd filed Critical Nicoventures Trading Ltd
Publication of NZ775291A publication Critical patent/NZ775291A/en
Publication of NZ775291B2 publication Critical patent/NZ775291B2/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A24TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24BMANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
    • A24B15/00Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
    • A24B15/10Chemical features of tobacco products or tobacco substitutes
    • A24B15/16Chemical features of tobacco products or tobacco substitutes of tobacco substitutes
    • A24B15/167Chemical features of tobacco products or tobacco substitutes of tobacco substitutes in liquid or vaporisable form, e.g. liquid compositions for electronic cigarettes
    • AHUMAN NECESSITIES
    • A24TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24BMANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
    • A24B15/00Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
    • A24B15/18Treatment of tobacco products or tobacco substitutes
    • A24B15/24Treatment of tobacco products or tobacco substitutes by extraction; Tobacco extracts
    • A24B15/241Extraction of specific substances
    • A24B15/243Nicotine
    • AHUMAN NECESSITIES
    • A24TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24BMANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
    • A24B15/00Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
    • A24B15/18Treatment of tobacco products or tobacco substitutes
    • A24B15/28Treatment of tobacco products or tobacco substitutes by chemical substances
    • A24B15/281Treatment of tobacco products or tobacco substitutes by chemical substances the action of the chemical substances being delayed
    • A24B15/283Treatment of tobacco products or tobacco substitutes by chemical substances the action of the chemical substances being delayed by encapsulation of the chemical substances
    • AHUMAN NECESSITIES
    • A24TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24BMANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
    • A24B15/00Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
    • A24B15/18Treatment of tobacco products or tobacco substitutes
    • A24B15/28Treatment of tobacco products or tobacco substitutes by chemical substances
    • A24B15/30Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances
    • AHUMAN NECESSITIES
    • A24TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24FSMOKERS' REQUISITES; MATCH BOXES; SIMULATED SMOKING DEVICES
    • A24F40/00Electrically operated smoking devices; Component parts thereof; Manufacture thereof; Maintenance or testing thereof; Charging means specially adapted therefor
    • A24F40/10Devices using liquid inhalable precursors

Landscapes

  • Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Toxicology (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Manufacture Of Tobacco Products (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

There is provided an aerosolised formulation comprising a vapour phase and a liquid water droplet phase, wherein the aerosolised formulation comprises (i) water in an amount of at least 50 wt.% based on the aerosolised formulation; (ii) one or more flavours; (iii) nicotine; (iv) 2-hydroxy-propyl derivatives of cyclodextrins and mixtures thereof; and (v) one or more acids; wherein at least 50 wt.% of the one or more flavours is present in the vapour phase, wherein an aerosol of the aerosolised formulation has a D10 of at least 0.5 µm.

Claims (26)

1. An aerosolised formulation comprising a vapour phase and a liquid water droplet phase, wherein the aerosolised formulation comprises 5 (i) water in an amount of at least 50 wt.% based on the aerosolised formulation; (ii) one or more flavours; (iii) nicotine; (iv) 2-hydroxy-propyl derivatives of cyclodextrins and mixtures thereof; and (v) one or more acids; 10 wherein at least 50 wt.% of the one or more flavours is present in the vapour phase, wherein an aerosol of the aerosolised formulation has a D10 of at least 0.5 µm.
2. An aerosolised formulation according to claim 1 wherein water is present in an amount of at least 75 wt.% based on the aerosolised formulation.
3. An aerosolised formulation according to claim 1 or 2 wherein water is present in an amount of at least 90 wt.% based on the aerosolised formulation.
4. An aerosolised formulation according to any one of claims 1 to 3 wherein the one or 20 more flavours are selected from the group consisting of (4-(para-)methoxyphenyl) butanone, vanillin, ?-undecalactone, menthone, 5-propenyl guaethol, menthol, para-mentha- 8-thiolone and mixtures thereof.
5. An aerosolised formulation according to claim 4 wherein the flavour is at least 25 menthol.
6. An aerosolised formulation according to any one of claims 1 to 5 wherein the one or more flavours are present in a total amount of no greater than 2wt.% based on the aerosolised formulation.
7. An aerosolised formulation according to any one of claims 1 to 6 wherein the one or more flavours are present in a total amount of from 0.01 to 1wt.% based on the aerosolised formulation. 35
8. An aerosolised formulation according to any one of claims 1 to 7 wherein at least 70 wt.% of the at least one flavour is present in the vapour phase.
9. An aerosolised formulation according to any one of claims 1 to 8 wherein at least 90 wt.% of the at least one flavour is present in the vapour phase.
10. An aerosolised formulation according to any one of claims 1 to 9 wherein at least 50 5 wt.% of the nicotine is present in the liquid water droplet phase.
11. An aerosolised formulation according to any one of claims 1 to 10 wherein at least 70 wt.% of the nicotine is present in the liquid water droplet phase 10
12. An aerosolised formulation according to any one of claims 1 to 11 wherein encapsulating material is present in a total amount of at least 1 wt.% based on the aerosolised formulation.
13. An aerosolised formulation according to any one of claims 1 to 12 wherein 15 encapsulating material is present in a total amount of no greater than 12 wt.% based on the aerosolised formulation.
14. An aerosolised formulation according to any one of claims 1 to 13 wherein the nicotine is present in an amount of no greater than 1wt.% based on the aerosolised 20 formulation.
15. An aerosolised formulation according to any one of claims 1 to 14 wherein the nicotine is present in an amount of from 0.01 to 0.6wt.% based on the aerosolised formulation.
16. An aerosolised formulation according to claim 1 wherein the acid is selected from the group consisting of acetic acid, lactic acid, formic acid, citric acid, benzoic acid, pyruvic acid, levulinic acid, succinic acid, tartaric acid, sorbic acid, propionic acid, phenylacetic acid, and mixtures thereof.
17. An aerosolised formulation according to claim 16 wherein the acid is selected from the group consisting of citric acid, benzoic acid, levulinic acid, sorbic acid, lactic acid, and mixtures thereof. 35
18. An aerosolised formulation according to any one of claims 16 or 17 wherein the acid is at least citric acid.
19. An aerosolised formulation according to any one of claims 1 to 18 wherein the aerosolisable formulation contains no flavours that can be encapsulated by the one or more cyclodextrins. 5
20. A process for forming an aerosol, the process comprising aerosolising an aerosolisable formulation comprising (i) water in an amount of at least 50 wt.% based on the aerosolised formulation; (ii) one or more flavours; (iii) nicotine; 10 (iv) 2-hydroxy-propyl derivatives of cyclodextrins and mixtures thereof; and (v) one or more acids; to provide an aerosol comprising a vapour phase and a liquid water droplet phase, wherein at least 50 wt.% of the one or more flavours is present in the vapour phase, wherein the aerosol has a D10 of at least 0.5 µm.
21. A process according to claim 20 wherein the aerosolisable formulation is a formulation as defined in any one of claims 2 to 19.
22. A process according to claim 20 or 21 wherein the aerosol is formed by a process 20 performed at a temperature below 50°C.
23. A process according to claim 20, 21 or 22 wherein the aerosol is formed by applying ultrasonic energy to the aerosolised formulation. 25
24. An electronic aerosol provision system comprising: (a) an aerosoliser for aerosolising formulation for inhalation by a user of the electronic aerosol provision system; (b) a power supply comprising a cell or battery for supplying power to the aerosoliser (c) aerosolisable formulation comprising 30 (i) water in an amount of at least 50 wt.% based on the aerosolised formulation; (ii) one or more flavours; (iii) nicotine; (iv) 2-hydroxy-propyl derivatives of cyclodextrins and mixtures thereof; and (v) one or more acids; 35 wherein the aerosoliser provides an aerosol comprising a vapour phase and a liquid water droplet phase, wherein at least 50 wt.% of the one or more flavours is present in the vapour phase, wherein the aerosol has a D10 of at least 0.5 µm.
25. An electronic aerosol provision system according to claim 24 wherein the aerosolised formulation is an aerosolised formulation as defined in any one of claims 2 to 19. 5
26. A process for improving delivery of flavour to an aerosolised formulation, the process comprising the steps of (a) providing an aerosolisable composition comprising (i) water in an amount of at least 50 wt.% based on the aerosolised formulation; (ii) one or more flavours; 10 (iii) nicotine; (iv) 2-hydroxy-propyl derivatives of cyclodextrin and mixtures thereof; and (v) one or more acids; (b) aerosolising the aerosolisable composition to provide an aerosol comprising a vapour phase and a liquid water droplet phase, wherein at least 50 wt.% of the one or more flavours 15 is present in the vapour phase, wherein the aerosol has a D10 of at least 0.5 µm. -1 -0.5 0 0.5 1.0 1.5 log [conc]
NZ775291A 2019-10-31 Aerosolisable formulation NZ775291B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB1817862.4A GB201817862D0 (en) 2018-11-01 2018-11-01 Aerosolisable formulation
PCT/GB2019/053089 WO2020089635A1 (en) 2018-11-01 2019-10-31 Aerosolisable formulation

Publications (2)

Publication Number Publication Date
NZ775291A true NZ775291A (en) 2024-09-27
NZ775291B2 NZ775291B2 (en) 2025-01-07

Family

ID=

Also Published As

Publication number Publication date
JP2024024046A (en) 2024-02-21
BR112021008561A2 (en) 2021-08-03
IL282461A (en) 2021-06-30
CN113038842B (en) 2023-11-03
US20230165299A1 (en) 2023-06-01
EP3873243A1 (en) 2021-09-08
JP2022506102A (en) 2022-01-17
KR102782830B1 (en) 2025-03-14
MY205404A (en) 2024-10-20
US12193471B2 (en) 2025-01-14
IL282461B1 (en) 2024-07-01
IL282461B2 (en) 2024-11-01
EP3873243B1 (en) 2025-07-23
GB201817862D0 (en) 2018-12-19
WO2020089635A1 (en) 2020-05-07
AU2019370809B2 (en) 2022-12-01
CA3118047A1 (en) 2020-05-07
AU2019370809A1 (en) 2021-05-20
UA127837C2 (en) 2024-01-17
PL3873243T3 (en) 2025-11-12
KR20210070333A (en) 2021-06-14
MX2021005117A (en) 2021-06-15
CN113038842A (en) 2021-06-25

Similar Documents

Publication Publication Date Title
IL305868A (en) Vaporisable formulation
NZ775291A (en) Aerosolisable formulation
NZ775291B2 (en) Aerosolisable formulation
IL274138B2 (en) Flavoured vaporisable formulation
CN103865276A (en) Active antibacterial edible package with controlled release function and preparation method thereof
NZ775136A (en) Aerosolisable formulation
NZ775136B2 (en) Aerosolisable formulation
NZ775331A (en) Aerosolisable formulation
NZ775294B2 (en) Aerosolised formulation
NZ775331B2 (en) Aerosolisable formulation
NZ775294A (en) Aerosolised formulation
NZ775410B2 (en) Aerosolisable formulation
NZ775410A (en) Aerosolisable formulation
NZ775338B2 (en) Aerosolised formulation
NZ775338A (en) Aerosolised formulation
NZ775353A (en) Aerosolisable formulation
NZ775417A (en) Aerosolisable formulation
CN102524243A (en) Preservative for fresh flower
NZ775417B2 (en) Aerosolisable formulation
NZ775292A (en) Aerosolisable formulation
RU2021112009A (en) AEROSOL-CAPABLE COMPOSITION
NZ775292B2 (en) Aerosolisable formulation
CN118489745A (en) A kind of emulsion coating preservative with fast curing performance and its preparation method and application
RU2021112078A (en) COMPOSITION CAPABLE OF FORMING AEROSOL, METHOD FOR ITS FORMATION AND ELECTRONIC AEROSOL PROVISION SYSTEM
CN101536635A (en) Method for reducing nicotine content

Legal Events

Date Code Title Description
PSEA Patent sealed
RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 31 OCT 2026 BY MS. MANDY LAUBACH

Effective date: 20251021